NURECA Stock Overview
Provides home healthcare and wellness products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Nureca Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹274.05 |
| 52 Week High | ₹468.80 |
| 52 Week Low | ₹240.00 |
| Beta | 0.42 |
| 11 Month Change | -3.42% |
| 3 Month Change | -10.89% |
| 1 Year Change | -22.64% |
| 33 Year Change | -81.99% |
| 5 Year Change | n/a |
| Change since IPO | -57.56% |
Recent News & Updates
Nureca Limited (NSE:NURECA) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Sep 06
We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope
Jul 12Recent updates
Nureca Limited (NSE:NURECA) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected
Sep 06We Think Nureca Limited's (NSE:NURECA) CEO Compensation Package Needs To Be Put Under A Microscope
Jul 12Nureca Limited (NSE:NURECA) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Mar 29Nureca Limited's (NSE:NURECA) Shares Not Telling The Full Story
Jun 19Robust Earnings May Not Tell The Whole Story For Nureca (NSE:NURECA)
Jun 23Shareholder Returns
| NURECA | IN Medical Equipment | IN Market | |
|---|---|---|---|
| 7D | 1.0% | -1.7% | 0.3% |
| 1Y | -22.6% | 66.2% | 27.3% |
Return vs Industry: NURECA underperformed the Indian Medical Equipment industry which returned 66.2% over the past year.
Return vs Market: NURECA underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| NURECA volatility | |
|---|---|
| NURECA Average Weekly Movement | 8.3% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: NURECA's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: NURECA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 138 | Aryan Goyal | www.nureca.com |
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, connected products, glucose meters, and thermometers; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, personal scales, massagers, yoga and exercise products, fitness tracking products, and dental and personal care products. It also provides mother and baby care products comprising baby feeding products, carry cots, baby skincare products, and bottle warmers and steamers; nutritional supplements and weight management products; and ECG products, blood pressure monitors, glucometer, fitness trackers, and smart weighing scales.
Nureca Limited Fundamentals Summary
| NURECA fundamental statistics | |
|---|---|
| Market cap | ₹2.78b |
| Earnings (TTM) | -₹28.01m |
| Revenue (TTM) | ₹908.02m |
3.0x
P/S Ratio-97.8x
P/E RatioIs NURECA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NURECA income statement (TTM) | |
|---|---|
| Revenue | ₹908.02m |
| Cost of Revenue | ₹597.41m |
| Gross Profit | ₹310.61m |
| Other Expenses | ₹338.62m |
| Earnings | -₹28.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.80 |
| Gross Margin | 34.21% |
| Net Profit Margin | -3.08% |
| Debt/Equity Ratio | 1.2% |
How did NURECA perform over the long term?
See historical performance and comparison